Alzchem Group AGXTER:ACT -0.57%56 ROC (Joel Greenblatt) % is 27.69% as of Mar. 2026, which is 56% above its 10-year median of 17.73. GuruFocus rates XTER:ACT with a GF Score™ of 56/100. The stock has 4 warning signs investors should review. Among 1,606 Chemicals companies, Alzchem Group AG ranks better than 86.74% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Alzchem Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 27.69%.
The historical rank and industry rank for Alzchem Group AG's ROC (Joel Greenblatt) % or its related term are showing as below:
XTER:ACT'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 12.57 Med: 17.73 Max: 28.97
Current: 28.97
During the past 13 years, Alzchem Group AG's highest ROC (Joel Greenblatt) % was 28.97%. The lowest was 12.57%. And the median was 17.73%.
XTER:ACT's ROC (Joel Greenblatt) % is ranked better than 86.74% of 1606
companies
in the Chemicals industry
Industry Median: 9.38
vs XTER:ACT: 28.97
Alzchem Group AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 18.30% per year.
Alzchem Group AG (XTER:ACT) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Alzchem Group AG ROC (Joel Greenblatt) % Related Terms
Alzchem Group AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Alzchem Group AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:ACT vs LIN, SHW, ECL: ROC (Joel Greenblatt) % Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG ROC (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's ROC (Joel Greenblatt) % falls into.
Alzchem Group AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 27.69% mean?
Alzchem Group AG (XTER:ACT) has a ROC (Joel Greenblatt) % of 27.69% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Alzchem Group AG and its competitors. This is 56% above median its historical median of 17.73. Over the past decade, Alzchem Group AG's ROC (Joel Greenblatt) % has ranged from 12.57 to 28.97. According to the industry distribution chart, Alzchem Group AG ranks #213 out of 1606 companies in the Chemicals industry, placing it in the top 13.3%.
Is Alzchem Group AG's ROC (Joel Greenblatt) % too high?
Alzchem Group AG's current ROC (Joel Greenblatt) % of 27.69% is 56% above median its 10-year median of 17.73. Over the past 10 years, this metric has ranged from a low of 12.57 to a high of 28.97. The Chemicals industry median ROC (Joel Greenblatt) % is 9.38. Alzchem Group AG's value of 27.69% is 195.2% above this industry median. Based on the distribution chart, Alzchem Group AG ranks #213 out of 1606 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Alzchem Group AG has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's ROC (Joel Greenblatt) % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #213 out of 1606 companies for ROC (Joel Greenblatt) %. This places Alzchem Group AG in the top 13% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 9.38. Alzchem Group AG's value of 27.69% is 195.2% above this benchmark. Historically, Alzchem Group AG's own ROC (Joel Greenblatt) % has ranged from 12.57 to 28.97 over the past decade. While the company's 10-year median is 17.73 vs. the industry median of 9.38, Alzchem Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Chemicals company?
The median ROC (Joel Greenblatt) % among Chemicals companies is 9.38, based on 1,606 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alzchem Group AG's current ROC (Joel Greenblatt) % of 27.69% is 195.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Alzchem Group AG and its competitors. For the Chemicals industry, the median ROC (Joel Greenblatt) % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzchem Group AG's current ROC (Joel Greenblatt) % is 27.69%, which is 56% above median its own 10-year median of 17.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current ROC (Joel Greenblatt) % of 27.69%. The current ROC (Joel Greenblatt) % is 27.69%, which is 56% above median its 10-year median of 17.73 and 195.2% above the Chemicals industry median of 9.38. Alzchem Group AG's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current ROC (Joel Greenblatt) % is 27.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
56GF Score
Get the complete analysis for XTER:ACT
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:ACT has been successfully added to your 
